The role of inflammatory cytokines on the aetiopathogenesis of depression

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 9, 2013, Pages 828-839

  Makhija, Karan ^a   Karunakaran, Satish ^a  

^a Towsnville Hospital   (Australia)

Author keywords

Cytokines; depression; immune response; inflammation

Indexed keywords

ALBUMIN; ALPHA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CERULOPLASMIN; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMATE TRANSPORTER; GLUTATHIONE PEROXIDASE; HYDROCORTISONE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SEROTONIN; SUPEROXIDE DISMUTASE; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; TYPHOID VACCINE; UBIDECARENONE;

ACTIVE TRANSPORT; ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; APOPTOSIS; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN REGION; CALCIUM TRANSPORT; CHEMICAL STRUCTURE; CHRONIC STRESS; CONFORMATIONAL TRANSITION; COPING BEHAVIOR; CROHN DISEASE; CYTOKINE PRODUCTION; DEPRESSION; DIETARY INTAKE; DISEASE PREDISPOSITION; DISTRESS SYNDROME; DNA DAMAGE; ENTERITIS; EXCITOTOXICITY; FOLLOW UP; FOOD INTAKE; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOGENICITY; LOCUS CERULEUS; MAJOR DEPRESSION; MENTAL STRESS; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NITROSATIVE STRESS; ORBITAL CORTEX; OXIDATIVE STRESS; PHENOTYPE; PREFRONTAL CORTEX; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEROTONIN METABOLISM; SLEEP PATTERN; SYSTEMATIC REVIEW;

CYTOKINES; DEPRESSION; IMMUNE RESPONSE; INFLAMMATION;

APOPTOSIS; BRAIN; CYTOKINES; DEPRESSION; HIPPOCAMPUS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEUROGENESIS; PITUITARY ACTH HYPERSECRETION; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 84884169056     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413488220     Document Type: Review

References (99)

1. Anacker C, Zunszain P, Cattaneo A, et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular Psychiatry. 2011 ; 16: 738-750
2. Barrientos R, Sprunger D, Campeau S, et al. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation in blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience. 2003 ; 121: 847-853
3. Baune B, Smith E, Reppermund S, et al. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology. 2012 ; 37: 1521-1530
4. Belanoff J, Rothschild A, Cassidy F, et al. An open label trial of C-1703 (mifepristone) for psychotic major depression. Biological Psychiatry. 2002 ; 52: 386-392
5. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 2011 ; 35: 804-817
6. Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of Sciences, USA. 2003 ; 199: 1920-1925
7. Bloch S, Singh B Foundations of clinical psychiatry. Melbourne, Australia: Melbourne University Press ; 2007 :
8. Bonaccorso S, Puzella A, Marino V, et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research. 2001 ; 105: 45-55
9. Brydon L, Harrison N, Walker C, et al. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biological Psychiatry. 2008 ; 63: 1022-1029
10. Bufalino C, Hepgul N, Aguglia E, et al. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain, Behavior and Immunity. 2012 2012 ;:
11. Bull S, Huezo-Diaz P, Binder EB, et al. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry. 2009 ; 14: 1095-1104
12. Capuron L, Miller A. Immune system to brain signalling: neuropsychopharmacological implications. Pharmacology and Therapeutics. 2011 ; 130: 226-238
13. Carroll B. The dexamethasone suppression test for melancholia. British Journal of Psychiatry. 1982 ; 140: 292-304
14. Caspi A, Sugden T, Mofitt A, et al. Influence of life stress on depression: moderation by a polymorphisms in the 5-HTT gene. Science. 2003 ; 301: 386-389
15. Christmas D, Potokar J, Davies S. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatric Disease and Treatment. 2011 ; 7: 431-439
16. Czeh B, Lucassen P. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257: 250-260
17. Dickens C, McGowan L, Clark-Carter D, et al. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosomatic Medicine. 2002 ; 64: 52-60
18. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biological Psychiatry. 2010 ; 67: 446-457
19. Eisch A, Petrik D. Depression and hippocampal neurogenesis: a road to remission?. Science. 2012 ; 338: 72-75
20. Fanselow M. Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research. 2000 ; 110: 73-81
21. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2′- deoxyguanosine in clinical depression. Psychosomatic Medicine. 2006 ; 68: 1-7
22. Frank M, Baratta M, Sprunger D, et al. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain, Behavior and Immunity. 2007 ; 21: 47-59
23. Fredricks C, Drabant E, Edge M, et al. Healthy young women with serotonin transporter SS polymorphism show a proinflammatory bias under resting and stress conditions. Brain, Behavior and Immunity. 2010 ; 24: 350-357
24. Galecki P, Szemraj J, Bienkiewicz M, et al. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Human Psychopharmacology. 2009 ; 24: 277-286
25. Gallagher PJ, Castro V, Fava M, et al. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilane study. American Journal of Psychiatry. 2012 ; 169: 1065-1072
26. Graff L, Walker J, Bernstein C. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflammatory Bowel Disease. 2009 ; 15: 1105-1118
27. Hibbeln JR. Fish consumption and major depression. Lancet. 1998 1213 ; 351 :
28. Hu S, Sheng W, Ehrlich L, et al. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation. 2000 ; 7: 153-159
29. Hwang J, Tsai S, Hong C, et al. Interleukin-1 beta -511 C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromoleular Medicine 11. 2009 ;:
30. Johnson J, Campisi J, Sharkey C, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005 ; 135: 1295-1307
31. Karg K, Burmeister M, Shedden K, et al. The serotonin transporter variant (5-HTTLPR), stress and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry. 2011 ; 68: 444-454
32. Kessler R, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Republication. JAMA. 2003 ; 289: 3095-3105
33. Koolschijn M, van Haren Neeltje E, Gerty J, et al. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Human Brain Mapping. 2009 ; 30: 3719-3735
34. Krishnadas R, Cavanagh J. Depression: an inflammatory illness?. Journal of Neurology, Neurosurgery and Psychiatry. 2012 ; 83: 495-502
35. Krishnadas R, Mallon V, McInnes I, et al. Correlates of depression and quality of life in patients with inflammatory arthrides. European Psychiatry. 2011 ; 26: 383
36. Kubera M, Lin AH, Kenis G, et al. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. Journal of Clinical Psychopharmacology. 2001 ; 21: 199-206
37. Kubera M, Obuchowicz E, Goehler L, et al. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011 ; 35: 744-759
38. Kunugi H, Hori H, Numakawa T, et al. The hypthalamic-pituitary-adrenal axis and depressive disorder: recent progress. Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 ; 32: 203-209
39. Lee A, Ogle W, Sapolsky R. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disorders. 2002 ; 4: 117-128
40. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience and Biobehavioral Reviews. 2012 ; 36: 764-785
41. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. Journal of Clinical Psychiatry. 2007 ; 68: 1056-1061
42. Liu Y, Ho R, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R- are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders. 2011 ; 139: 230-239
43. Lo Fermo S, Barone R, Patti F, et al. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Multiple Sclerosis. 2010 ; 16: 742-748
44. Lopez-Duran N, Kovacs M, George C. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendocrinology. 2009 ; 34: 1272-1283
45. MacQueen G, Campbell S, McEwen B, et al. Course of illness, hippocampal function and hippocampal volume in major depression. Proceedings of the National Academy of Sciences, USA. 2003 ; 100: 1387-1392
46. Maes M. A review on the acute phase response in major depression. Reviews in the Neurosciences. 1993 ; 4: 407-416
47. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-psychopharmacology and Biological Psychiatry. 1995 ; 19: 11-38
48. Maes M, Bosmans E, De Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokines. 1997 ; 9: 853-858
49. Maes M, De Vos N, Pioli R, et al. Lower serum vitamin E concentrations in major depression: another marker of lowered antioxidant defenses in that illness. Journal of Affective Disorders. 2000 ; 58: 241-246
50. Maes M, Galecki P, Chang YS, et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011 ; 35: 676-692
51. Maes M, Meltzer HY, Scharpe S, et al. Relationships between lower plasma l-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Research. 1993a ; 49: 151-165
52. Maes M, Mihaylova I, Leunis JC. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinology Letters. 2007 ; 28: 861-867
53. Maes M, Mihaylova I, Kubera M, et al. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012 ; 36: 169-175
54. Maes M, Scharpe S, Meltzer HY, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary- adrenal axis in severe depression. Psychiatry Research. 1993b ; 49: 11-27
55. Maes M, Song C, Lin AH, et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 1999 ; 20: 370-379
56. Maes M, Yirmyia R, Noraberg J, et al. The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease. 2009 ; 24: 27-53
57. Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006 ; 3: 422
58. Mayer J, Klumpers L, Maslam S, et al. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. Journal of Neuroendocrinology. 2006 ; 18: 629-631
59. Mazzeo R, Donovan D, Fleshner M, et al. Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade. Journal of Applied Physiology. 2001 ; 91: 2143-2149
60. Miller A, Timmie W. Mechanisms of cytokine0induced behavioural changes: psychoneuroimmunology at the translational interface. Brain, Behavior and Immunity. 2008 ; 23: 149-158
61. Miller A, Maletic V, Raison C. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry. 2009a ; 65: 732-741
62. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysilogy of major depression. Biological Psychiatry. 2009b ; 65: 732-741
63. Muller N, Schwarz MJ, Dehning S, et al. The cyclooxygenase-2 inhibitor celecoxib has theraputic effects in major depression: results of a double-blood randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry. 2006 ; 11: 680-684
64. Myint A, Schwarz M, Steinbusch H, et al. Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease. 2009 ; 24: 55-68
65. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses. 2003 ; 61: 519-525
66. Otte C, McCaffery J, Ali S, et al. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the heart and soul study. American Journal of Psychiatry. 2007 ; 164: 1379-1384
67. Ozcan ME, Gulec M, Ozerol E, et al. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology. 2004 ; 19: 89-95
68. Pace T, Miller A. Cytokines and glucocorticoid receptor signialing relevance to major depression. Ann. N.Y. Acad. Sci. 2009 ; 1179: 86-105
69. Pace T, Hu F, Miller A. Cytokine-effects on glucorticoid receptor function: relevance to glucorticoid resistance and the pathophysiology and treatment of major depression. Brain, Behavior and Immunity. 2011 ; 21: 9-19
70. Pace T, Mletzko T, Alagbe D, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry. 2006 ; 163: 1630-1633
71. Palazidou E. The neurobiology of depression. British Medical Bulliten. 2012 ; 101: 127-145
72. Pascoe M, Crewther S, Carey L, et al. Inflammation and depression: why poststroke depression may be the norm and not the exception. International Journal of Stroke. 2011 ; 6: 128-135
73. Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short-and long-term outcomes of Crohn's disease treatment with inflixmiab. Alimentary Pharmacology and Therapeutics. 2005 ; 22: 101-110
74. Petrik D, Lagace C, Eisch A. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?. Neuropharmacology. 2012 ; 62: 21
75. Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for "depression due to a general medical condition", immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology. 2002 ; 5: 389-399
76. Raedler T. Inflammatory mechanisms in major depressive disorder. Current Opinion in Psychiatry. 2011 ; 24: 519-525
77. Raison C, Miller A. Is depression an inflammatory disorder?. Current Psychiatry Reports. 2011 ; 13: 467-475
78. Raison C, Borisov A, Majer M, et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry. 2008 ; 65: 296-303
79. Raison C, Capuron L, Miller A. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology. 2006 ; 27: 24-31
80. Reichenbert A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry. 2001 ; 58: 445-452
81. Reul J, deKloet E. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitra autoradiography and computerized image analysis. Journal of Steroid Biochemistry. 1986 ; 24: 269-272
82. Rosa A, Peralta V, Papiol S, et al. Interleuin 1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. American Journal of Medical Genetics B Neuropsychiatric Genetics. 2004 ; 124B: 10-14
83. Schmidt H, Shelton R, Duman R. Functional biomarkers of depression: diagnosis, treatment and pathophysiology. Neuropsychopharmacology. 2011 ; 36: 2375-2394
84. Seidel A, Arolt V, Hunstiger M, et al. Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology. 1995 ; 41: 534-538
85. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry. 2003 ; 54: 70-75
86. Sluzewska A, Rybakowski J, Bosmans E, et al. Indicators of immune activation in major depression. Psychiatry Research. 1996 ; 64: 161-167
87. Smith RS. The macrophage theory of depression. Medical Hypotheses. 1991 ; 35: 298-306
88. Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. Journal of Affective Disorders. 1994 ; 30: 283-288
89. Stellwagen D, Beattie E, Seo J, et al. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. Journal of Neuroscience. 2005 ; 25: 3219-3228
90. Su K, Huang S, Peng C, et al. Phospholipase A2 and cyclooxygenase 2 genes incluence the risk of interferon-alpha-induced depression by regulatnig polyunsaturated fatty acids lvels. Biological Psychiatry. 2010 ; 67: 550-557
91. Su S, Zhao J, Bremner J, et al. Serotonin transporter gene, depressive symptoms and interleukin-6. Circulation and Cardiovascular Genetics. 2009 ; 2: 614-620
92. Thakker-Varia S, Krol JJ, Nettleton J, et al. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. Journal of Neuroscience. 2007 ; 27: 12156-12167
93. Tsankova N, Berton O, Renthal W, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience. 2006 ; 9: 519-525
94. Turner CA, Akil H, Watson SJ, et al. The fibroblast growth factor system and mood disorders. Biological Psychiatry. 2006 ; 59: 1128-1135
95. Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006 ; 367: 29-35
96. Viviani B, Bartesaghi S, Gardoni F, et al. Interlukin-1 beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. Journal of Neuroscience. 2003 ; 23: 8692-8700
97. Wu C, Chen Y, Yu L, et al. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. Journal of Neurochemisty. 2007 ; 103: 2471-2481
98. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 1996 ; 34: 27-37
99. Zunszain P, Anacker C, Cattaneo A, et al. Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuropsychopharmacology and Biological Psychiatry. 2011 ; 35: 722-729